(Q40373550)

19 September 2017

Introduction to Bayesian methods III: use and interpretation of Bayesian tools in design and analysis (English)

1 reference

19 September 2017

Donald A Berry

1

1 reference

19 September 2017

1 January 2005

1 reference

19 September 2017

1 reference

19 September 2017

2

1 reference

19 September 2017

295-300; discussion 301-4, 364-78

1 reference

19 September 2017

4

1 reference

Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer

19 September 2017

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN100OA

Crossref

reference URL

Adaptive randomized study of idarubicin and cytarabine versus troxacitabine and cytarabine versus troxacitabine and idarubicin in untreated patients 50 years or older with adverse karyotype acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN100OA

Crossref

reference URL

The new math of clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN100OA

Crossref

reference URL

10.1191/1740774505CN100OA

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference

PubMed ID

16281428